{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T02:45:26Z","timestamp":1789008326036,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.jhep.2005.12.016","type":"journal-article","created":{"date-parts":[[2006,2,4]],"date-time":"2006-02-04T15:29:32Z","timestamp":1139066972000},"page":"791-797","source":"Crossref","is-referenced-by-count":70,"title":["Clinical characteristics and prognostic markers in disulfiram-induced liver injury"],"prefix":"10.1016","volume":"44","author":[{"given":"Einar","family":"Bj\u00f6rnsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Nordlinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2005.12.016_bib1","doi-asserted-by":"crossref","first-page":"943","DOI":"10.7326\/0003-4819-111-11-943","article-title":"Disulfiram treatment of alcoholism. American College of Physicians paper","volume":"111","author":"Wright","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2005.12.016_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0447.1992.tb03316.x","article-title":"Controlled trials of Antabuse in alcoholism: the importance of supervision and adequate dosage","volume":"369","author":"Brewer","year":"1992","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jhep.2005.12.016_bib3","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1093\/ajhp\/61.21.2272","article-title":"Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 1","volume":"61","author":"Kenna","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jhep.2005.12.016_bib4","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1093\/ajhp\/61.22.2380","article-title":"Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2","volume":"61","author":"Kenna","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jhep.2005.12.016_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1001\/jama.230.3.435","article-title":"Disulfiram hypersensitivity","volume":"230","author":"Keeffe","year":"1974","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jhep.2005.12.016_bib6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.7326\/0003-4819-83-5-673_2","article-title":"Letter: disulfiram hepatotoxicity","volume":"83","author":"Eisen","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2005.12.016_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1136\/bmj.2.6079.94","article-title":"Disulfiram hepatotoxicity","volume":"2","author":"Ranek","year":"1977","journal-title":"Br Med J"},{"key":"10.1016\/j.jhep.2005.12.016_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0016-5085(78)93772-1","article-title":"Disulfiram hepatitis","volume":"75","author":"Morris","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2005.12.016_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.0954-6820.1981.tb11603.x","article-title":"Toxic hepatitis induced by disulfiram in a non-alcoholic","volume":"209","author":"Kristensen","year":"1981","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jhep.2005.12.016_bib10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/BF01309513","article-title":"Disulfiram-induced hepatitis. Report of two cases and review of the literature","volume":"30","author":"Bartle","year":"1985","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2005.12.016_bib11","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archinte.1983.00350060203038","article-title":"Fulminant hepatitis associated with disulfiram. Report of a case","volume":"143","author":"Schade","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jhep.2005.12.016_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/106002808902301107","article-title":"Disulfiram-induced hepatitis: case report and review of the literature","volume":"23","author":"Mason","year":"1989","journal-title":"DICP"},{"key":"10.1016\/j.jhep.2005.12.016_bib13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0168-8278(94)80249-1","article-title":"Disulfiram-induced hepatitis. Report of four cases and review of the literature","volume":"21","author":"Forns","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2005.12.016_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-0447.1992.tb03317.x","article-title":"Disulfiram therapy\u2014adverse drug reactions and interactions","volume":"369","author":"Enghusen Poulsen","year":"1992","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.jhep.2005.12.016_bib15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.0954-6820.1979.tb06083.x","article-title":"Fatal reactions to drugs","volume":"205","author":"B\u00f6ttiger","year":"1979","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jhep.2005.12.016_bib16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1053\/jhep.2003.50284","article-title":"Drug-induced hepatic injury in Sweden","volume":"38","author":"Olsson","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.12.016_bib17","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2014I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jhep.2005.12.016_bib18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2005.12.016_bib19","doi-asserted-by":"crossref","unstructured":"Senior JR. Regulatory perspectives. In: Kaplowitz N, DeLeve LD, editors. Drug-induced liver disease; 2003. p. 739\u201354.","DOI":"10.1201\/9780203909126.pt4"},{"key":"10.1016\/j.jhep.2005.12.016_bib20","series-title":"Guidelines for detection of hepatotoxicity due to drugs and chemicals [Fogarthy Conference, 1978]. NIH publication No. 79-313","year":"1979"},{"key":"10.1016\/j.jhep.2005.12.016_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers markers in sever drug-induced liver disease","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2005.12.016_bib22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2005.12.016_bib23","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1136\/bmj.319.7224.1541","article-title":"Accuracy of hepatic adverse drug reaction reporting in one English health region","volume":"319","author":"Aithal","year":"1999","journal-title":"Br Med J"},{"key":"10.1016\/j.jhep.2005.12.016_bib24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00365520510023846","article-title":"Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden","volume":"40","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2005.12.016_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.15288\/jsa.1979.40.133","article-title":"Hepatotoxicty in Disulfiram treated patients","volume":"40","author":"Goyer","year":"1979","journal-title":"J Stud Alcohol"},{"key":"10.1016\/j.jhep.2005.12.016_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1600-0536.1983.tb04394.x","article-title":"Treatment of nickel dermatitis with antabuse: a double blind study","volume":"9","author":"Kaaber","year":"1983","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jhep.2005.12.016_bib27","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1530-0277.1993.tb00745.x","article-title":"Screening for disulfiram-induced liver test dysfunction in an in-patient alcoholism program","volume":"17","author":"Wright","year":"1993","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2005.12.016_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1530-0277.1987.tb01312.x","article-title":"Liver toxicity encountered in the Veterans Administration trial of disulfiram in alcoholics","volume":"11","author":"Iber","year":"1987","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jhep.2005.12.016_bib29","first-page":"84","volume":"161","author":"Chick","year":"1992","journal-title":"Disulfiram Treat Alcohol"},{"key":"10.1016\/j.jhep.2005.12.016_bib30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2165\/00002018-199920050-00003","article-title":"Safety issues concerning the use of disulfiram in treating alcohol dependence","volume":"20","author":"Chick","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2005.12.016_bib31","first-page":"252","article-title":"Metronidazol as a probable cause of severe liver injury","volume":"49","author":"Bj\u00f6rnsson","year":"2002","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhep.2005.12.016_bib32","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3109\/00365529709007690","article-title":"Liver reactions to oral low-dose tetracyclines","volume":"32","author":"Bj\u00f6rnsson","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2005.12.016_bib33","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0168-8278(92)90029-O","article-title":"Liver damage from flucloxacillin, cloxacillin and dicloxacillin","volume":"15","author":"Olsson","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2005.12.016_bib34","first-page":"241","article-title":"Disulfiram hepatotoxicity: a consideration of its mechanism and clinical spectrum","volume":"24","author":"Berlin","year":"1989","journal-title":"Alcohol Alcoholism"},{"key":"10.1016\/j.jhep.2005.12.016_bib35","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0168-8278(98)80264-X","article-title":"Expression of autoantibodies to specific cytochromes P450 in a case of disulfiram hepatitis","volume":"29","author":"Eliasson","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2005.12.016_bib36","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1172\/JCI114660","article-title":"Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P450IA2. A specific marker of dihydralazine-induced hepatitis","volume":"85","author":"Bourdi","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2005.12.016_bib37","first-page":"573","article-title":"Cytochrome P450 2E1 is a cell surface autoantigen in halthane hepatitis","volume":"50","author":"Eliasson","year":"1996","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jhep.2005.12.016_bib38","first-page":"38","article-title":"Immunological mechansisms of drug-induced liver injury","volume":"8","author":"Ju","year":"2005","journal-title":"Curr Opin Drug Discov Develop"},{"key":"10.1016\/j.jhep.2005.12.016_bib39","first-page":"430","article-title":"Disulfiram-induced fulminant hepatitis: guidelines for liver-panel monitoring","volume":"49","author":"Wright","year":"1988","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jhep.2005.12.016_bib40","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4088\/JCP.v59n0607","article-title":"Disulfiram use in patients with abnormal liver function tests","volume":"59","author":"Saxon","year":"1998","journal-title":"J Clin Psychiatry"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T13:02:12Z","timestamp":1586696532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827806000079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0168827806000079"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2005.12.016","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]}}}